Shire and TAP to co-promote ulcerative colitis drug Lialda - Pharma Times (subscription)
|
Shire and TAP to co-promote ulcerative colitis drug Lialda
Pharma Times (subscription), UK - 3 hours ago … and while that blow will be softened follow-up drug Vyvanse (lisdexamfetamine dimesylate), “the bigger picture for Shire is its developing product … |
Find Out More:
Books:
- The Social Skills Picture Book Teaching play, emotion, and communication to children with autism
- Concerta Side Effects
- Ritalin Is Not The Answer: A Drug-Free, Practical Program for Children Diagnosed with ADD or ADHD
- Physical Activities for Improving Children’s Learning and Behavior
- ADHD: Attention-Deficit Hyperactivity Disorder in Children, Adolescents, and Adults
March 27th, 2008
Vyvanse
Leave a Reply